A ALNY
Alnylam Pharmaceuticals Inc
HEALTHCARE
$330.34
+3.60% (+$11.49)
Volume
1.27M
52W High
$495.55
52W Low
$205.87
Market Cap
$42.58B
What to Watch This Quarter
Based on historical dataConsensus EPS
$1.03
Whisper EPS
$1.18
15.0% above consensus
Last Quarter
$1.25
Current Streak
1 Meet
Avg Surprise (4Q)
+51.10%
Next Earnings Report
Reports in 30 days
Price Chart
EPS History: Consensus vs Actual
Last 12 quartersPrice Movement Around Earnings
Q4 2025
Feb 12, 2026
1-Day:
+1.92%
5-Day:
+7.82%
Q3 2025
Oct 30, 2025
1-Day:
+1.44%
5-Day:
-5.80%
Q2 2025
Jul 31, 2025
1-Day:
+2.44%
5-Day:
+6.80%
Q1 2025
May 1, 2025
1-Day:
+1.67%
5-Day:
+5.75%
Revenue & Financial Performance
Revenue Whisper
$993.0M
TWN Proprietary Estimate
Last Quarter Revenue
$1.10B
+85.0% YoY
Gross Margin
75.6%
Net Margin: 17.0%
| Quarter | Revenue | YoY Growth | Gross Margin | Op Margin | Net Income |
|---|---|---|---|---|---|
| Q4'25 | $1.10B | +85.0% | 75.6% | 12.0% | $186.4M |
| Q3'25 | $1.25B | +149.4% | 84.2% | 29.5% | $251.1M |
| Q2'25 | $773.7M | +17.3% | 81.5% | -2.1% | -$66.3M |
| Q1'25 | $594.2M | +20.2% | 88.0% | 3.0% | -$57.5M |
| Q4'24 | $593.2M | +34.9% | 82.7% | -17.7% | -$83.8M |
| Q3'24 | $500.9M | -33.3% | 82.9% | -15.4% | -$111.6M |
| Q2'24 | $659.8M | +107.0% | 89.6% | 7.4% | -$16.9M |
| Q1'24 | $494.3M | +54.8% | 86.7% | -8.8% | -$65.9M |
Company Information
Symbol
ALNY
Company
Alnylam Pharmaceuticals Inc
Market Cap
$42.58B
Sector
HEALTHCARE
Next Earnings
May 7, 2026
Also Reporting Soon
Companies reporting earnings around the same time as ALNY
HEALTHCARE Stocks
Other healthcare companies with earnings data
Compare ALNY with competitors
Side-by-side earnings comparison